Innovation, Science and Industry Minister Francois-Philippe Champagne has been in Japan for the past week, pitching Canada as a good location for production of electric vehicles and the batteries that power them.
While meeting with the presidents of Mitsubishi Tanabe Pharma and Mitsubishi Chemical, which owns a 79 per cent stake in Medicago, Champagne says there were discussions about the company’s future as a global vaccine manufacturer. Its biopharmaceutical vaccine has been rejected by the WHO because tobacco company Philip Morris is a minority shareholder, and the UN agency has a strict policy about engagement with the tobacco industry.
The Covifenz vaccine was licensed by Health Canada in February for adults aged 18 to 64, and the federal government has signed a contract to buy up to 76 million doses with plans to donate vaccines to low-income countries.Article contentChampagne says the government is working with the company to make Medicago “a global leader when it comes to global health.
United Kingdom United Kingdom Latest News, United Kingdom United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: globeandmail - 🏆 5. / 92 Read more »
Source: CTVNews - 🏆 1. / 99 Read more »
Source: TerraceStandard - 🏆 24. / 68 Read more »